Massachusetts reports drug makers' payments to US doctors, hospitals in a searchable database
This article was originally published in Scrip
Executive Summary
Massachusetts has begun disclosing on a single, searchable database a list of payments over $50 made by drug companies and device makers to the state's health care providers, including consulting and speaking fees, participation in a speaker's bureau, educational programmes and charitable donations. Companies do not have to disclose funding for research aimed at answering a legitimate scientific query.